These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 1832289

  • 21. Placebo-controlled study of oral enoximone in congestive heart failure with initial and final intravenous hemodynamic evaluation.
    Khalife K, Zannad F, Brunotte F, Belhadj K, Juilliere Y, Iannascoli F, Gilgenkrantz JM.
    Am J Cardiol; 1987 Aug 14; 60(5):75C-79C. PubMed ID: 2956874
    [Abstract] [Full Text] [Related]

  • 22. Comparative hemodynamic and hormonal response of enoximone and dobutamine in severe congestive heart failure.
    Uretsky BF, Generalovich T, Verbalis JG, Valdes AM, Reddy PS.
    Am J Cardiol; 1986 Jul 01; 58(1):110-6. PubMed ID: 2942027
    [Abstract] [Full Text] [Related]

  • 23. [Enoximone: hemodynamic effect in patients with cardiac insufficiency].
    de Langenhagen B, Bouchoucha H, Scholl JM, Hennetier G, Benacerraf A, Achard F, Bock F.
    Arch Mal Coeur Vaiss; 1990 Sep 01; 83 Spec No 3():19-25. PubMed ID: 2147830
    [Abstract] [Full Text] [Related]

  • 24. A dose-response study of intravenous enoximone in congestive heart failure.
    Erbel R, Meyer J, Diefenbach C, Delorme G, Bourdarias JP, Vernant P, Lellouche D, Mattioli G, Barbieri A, Installe E.
    Am J Cardiol; 1987 Aug 14; 60(5):31C-36C. PubMed ID: 2956865
    [Abstract] [Full Text] [Related]

  • 25. Differential hemodynamic effects of oral enoximone in severe congestive heart failure.
    Murali S, Uretsky BF, Betschart AR, Tokarczyk TR, Kolesar JA, Reddy PS.
    Am J Cardiol; 1990 Feb 15; 65(7):515-9. PubMed ID: 2137668
    [No Abstract] [Full Text] [Related]

  • 26. [Hemodynamic effects of new phosphodiesterase inhibitors in patients with coronary heart disease. A comparison between enoximone and R80122].
    Kazmaier S, Stephan H, Sonntag H.
    Anaesthesist; 1995 Jun 15; 44(6):410-6. PubMed ID: 7653792
    [Abstract] [Full Text] [Related]

  • 27. Cardiopulmonary effects of enoximone or dobutamine and nitroglycerin on mitral valve regurgitation and pulmonary venous hypertension.
    Hachenberg T, Möllhoff T, Holst D, Hammel D, Brüssel T.
    J Cardiothorac Vasc Anesth; 1997 Jun 15; 11(4):453-7. PubMed ID: 9187994
    [Abstract] [Full Text] [Related]

  • 28. Acute and long-term hemodynamic response to low-dose enoximone in refractory heart failure.
    McDonald KM, O'Sullivan JJ, McWilliams EW, Conroy RC, Maurer BJ.
    Cardiovasc Drugs Ther; 1989 Dec 15; 3(6):913-8. PubMed ID: 2535057
    [Abstract] [Full Text] [Related]

  • 29. Addition of enoximone to adrenergic agents in the management of severe heart failure.
    Vincent JL, Léon M, Berré J, Mélot C, Kahn RJ.
    Crit Care Med; 1992 Aug 15; 20(8):1102-6. PubMed ID: 1386567
    [Abstract] [Full Text] [Related]

  • 30. Effects of low dose enoximone for chronic congestive heart failure.
    Jessup M, Ulrich S, Samaha J, Helfer D.
    Am J Cardiol; 1987 Aug 14; 60(5):80C-84C. PubMed ID: 2956875
    [Abstract] [Full Text] [Related]

  • 31. A preliminary report of the effects of orally administered enoximone on regional hemodynamics in congestive heart failure.
    Leier CV, Meiler SE, Matthews S, Unverferth DV.
    Am J Cardiol; 1987 Aug 14; 60(5):27C-30C. PubMed ID: 2956864
    [Abstract] [Full Text] [Related]

  • 32. [Comparison of new cardiac agents using differential therapeutic criteria].
    Redmann K, Lunkenheimer PP, Rettig G, Isringhaus H, Flameng W, Demeyere R.
    Z Kardiol; 1991 Aug 14; 80 Suppl 4():7-14. PubMed ID: 1833902
    [Abstract] [Full Text] [Related]

  • 33. [Comparison of the hemodynamic effects of dobutamine and enoximone in the treatment of low cardiac output after valvular surgery].
    George M, Atallah G, Lehot JJ, Bastien O, Durand PG, Estanove S.
    Arch Mal Coeur Vaiss; 1990 Sep 14; 83 Spec No 3():57-62. PubMed ID: 2147836
    [Abstract] [Full Text] [Related]

  • 34. Effects of enoximone and R 80122, a new selective phosphodiesterase III inhibitor, on hemodynamics and myocardial energetics in patients with ischemic heart disease.
    Stephan H, Kazmaier S, Hoeft A, Sonntag H.
    Anesth Analg; 1994 Dec 14; 79(6):1059-65. PubMed ID: 7978427
    [Abstract] [Full Text] [Related]

  • 35. [The anti-ischemic effect of phosphodiesterase III inhibitors].
    Schlepper M.
    Z Kardiol; 1994 Dec 14; 83 Suppl 2():27-36. PubMed ID: 8091822
    [Abstract] [Full Text] [Related]

  • 36. Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
    Installe E, De Coster P, Gonzalez M, Brichant C, Lessire H, Cauwe F.
    Eur Heart J; 1991 Sep 14; 12(9):985-93. PubMed ID: 1834466
    [Abstract] [Full Text] [Related]

  • 37. Enoximone improves selection of candidates for urgent cardiac transplantation.
    Loisance D, Benvenuti C, Dubois Randé JL, Deleuze P, Castaigne A, Cachera JP.
    Int J Cardiol; 1990 Jul 14; 28 Suppl 1():S23-7. PubMed ID: 2145234
    [Abstract] [Full Text] [Related]

  • 38. The new phosphodiesterase inhibitor enoximone in patients following cardiac surgery--pharmacokinetics and influence on parameters of coagulation.
    Boldt J, Kling D, Dieterich HA, Marck P, Hempelmann G.
    Intensive Care Med; 1990 Jul 14; 16(1):54-9. PubMed ID: 2138182
    [Abstract] [Full Text] [Related]

  • 39. Effects of intracoronary infusion of an inotropic agent, E-1020 (loprinone hydrochloride), on cardiac function: evaluation of left ventricular contractile performance using the end-systolic pressure-volume relationship.
    Murakami R, Sano K, Murakami Y, Shimada T, Morioka S.
    Int J Cardiol; 1995 Aug 14; 51(1):57-63. PubMed ID: 8522398
    [Abstract] [Full Text] [Related]

  • 40. [Effect of oral administration of enoximone on cardiac performance, arterial circulation at rest and on the vasoconstrictor effect of local noradrenaline infusions into the human hand vein].
    Breithaupt K, Belz GG, Kempinski S, Schicketanz KH, Dieterich HA.
    Z Kardiol; 1991 Aug 14; 80 Suppl 4():15-20. PubMed ID: 1833892
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.